A private AgTech company, supported by F3 Tech, is developing a preventative & therapeutic solution to inhibit the binding & growth of SARS-COV-2 in human cells.

F3 Tech, a leading commercialization program for early-stage companies, today announced that it has been providing resources and advisory services to a private Maryland company that has been developing a COVID-19 preventative and therapeutic solution. The solution has demonstrated an ability to inhibit the binding and growth of SARS-CoV-2 in human cells. F3 Tech has been supporting the company’s research and development of the solution since May 2020.

@f3techMD #covid #covid-19 #agritech

Source: F3 Tech Supports Research for COVID-19 Preventative Solution